Relative safety and efficacy of finasteride for treatment of hirsutism

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 1070-1073

  Townsend, Kara A ^a,b   Marlowe, Karen F ^a,c  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Antiandrogens; Finasteride; Hirsutism

Indexed keywords

ANDROGEN; ANTIANDROGEN; FINASTERIDE; FLUTAMIDE; KETOCONAZOLE; SPIRONOLACTONE;

AMENORRHEA; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HAIR ANALYSIS; HAIR LOSS; HEADACHE; HIRSUTISM; HUMAN; HYPERANDROGENISM; LIVER TOXICITY; MENSTRUATION DISORDER; METRORRHAGIA; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMATIC REVIEW; TERATOGENICITY; TREATMENT OUTCOME; UTERUS BLEEDING;

ENZYME INHIBITORS; FEMALE; FINASTERIDE; HIRSUTISM; HUMANS; RANDOMIZED CONTROLLED TRIALS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 2442672007     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D461     Document Type: Article

References (22)

1. McKnight E. The prevalence of "hirsutism" in young women. Lancet 1964;1:410-3.
2. Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003;101:995-1007.
3. Bayram F, Muderris H, Sahin Y, Kelestimur F. Finasteride treatment for one year in 35 hirsute patients. Exp Clin Endocrinol Diabetes 1999;107:195-7.
4. Conn JJ, Jacobs HS. Managing hirsutism in clinical practice. Br J Obstet Gynaecol 1998;105:687-96.
5. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-30.
6. Knochenhauer ES, Azziz R. Advances in the diagnosis and treatment of the hirsute patient. Curr Opin Obstet Gynecol 1995;7:344-50.
7. Sawaya ME, Hordinsky MK. The antiandrogens: when and how they should be used. Dermatol Clin 1993;11:65-72.
8. Fruzzetti F, de Lorenzo D, Parrini D, Ricci C. Effects of finasteride, a 5-α-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. J Clin Endocrinol Metab 1994;79:831-5.
9. Castello R, Tosi F, Perrone F, Negri C, Muggeo M, Moghetti P. Outcome of long-term treatment with the 5 α reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Fertil Steril 1996;66:734-40.
10. Lucas KJ. Finasteride cream in hirsutism. Endocrine Pract 2001;7:5-10.
11. Tolino A, Petrone A, Sarnacchiaro F, Cirillo D, Ronsini S, Lombardi G, et al. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril 1996;66:61-5.
12. Ciotta L, Cianci A, Calogero AE, Palumbo MA, Marletta E, Sciuto A, et al. Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism. Fertil Steril 1995;64:299-306.
13. Price T, Allen S, Pegram GV. Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone. Fertil Steril 2000;74:414-5.
14. Faloia E, Filipponi S, Mancini V, DiMarco S, Mantero F. Effect of finasteride in idiopathic hirsutism. J Endocrinol Invest 1998;21:694-8.
15. Tartagni M, Schenauer L, De Salvia M, Cicinelli D, Pergoia G, D'Addario V. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril 2000;73:718-23.
16. Moghetti P, Tosi F, Tosti A, Negri C, Misciali C, Perrone F, et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2000;85:89-94.
17. Venturoli S, Marescalchi O, Colombo FM, Macrelli S, Ravaioli B, Bagnoli A, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole and cyproterone acetate-estrogen regimen in the treatment of hirsutism. J Clin Endocrinol Metab 1999;84:1304-10.
18. Lumachi F, Rondinone R. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism. Fertil Steril 2003;79:942-6.
19. Falsetti L, Gambera A, Legrenzi L, Iacobello C, Bugari G. Comparison of finasteride versus flutamide in the treatment of hirsutism. Eur J Endocrinol 1999;141:362-7.
20. Muderris I, Bayram F, Guven M. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Fertil Steril 2000;73:984-7.
21. Bayhan G, Bahceci M, Demirkol T, Ertem M, Yalinkaya A, Erden AC. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism. Clin Exp Obstet Gynecol 2000;27:203-6.
22. Package insert. Proscar (finasteride). Whitehouse Station, NJ: Merck and Company, January 2001.